Literature DB >> 7753203

Cytokines.

H Holtmann1, K Resch.   

Abstract

The defense of the organism against pathogens involves complex processes in which many different types of cells take part. Their functions are coordinated by polypeptide mediators collectively named cytokines. The intense research devoted to these molecules in the past has yielded an insight into their molecular characteristics, mode of action, physiological function, and their deleterious role in numerous diseases. Yet therapeutic application of that knowledge--either controlled administration of cytokines or neutralization of their negative effects in certain pathological processes--despite initial achievements has remained a major challenge.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753203     DOI: 10.1007/BF01143192

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  27 in total

1.  "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation.

Authors:  D C Dumonde; R A Wolstencroft; G S Panayi; M Matthew; J Morley; W T Howson
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

Review 2.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 3.  Commentary. Similarities of T cell function in cell-mediated immunity and antibody production.

Authors:  S Cohen; P E Bigazzi; T Yoshida
Journal:  Cell Immunol       Date:  1974-04       Impact factor: 4.868

4.  Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.

Authors:  H Holtmann; D Wallach
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

5.  Induction of human interleukin 1 mRNA measured by collagenase- and prostaglandin E2-stimulating activity in rheumatoid synovial cells.

Authors:  J M Dayer; C Zavadil-Grob; C Ucla; B Mach
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

6.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.

Authors:  S L Kunkel; M Spengler; M A May; R Spengler; J Larrick; D Remick
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

7.  Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

Authors:  J Van Damme; M De Ley; G Opdenakker; A Billiau; P De Somer; J Van Beeumen
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

8.  Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.

Authors:  Y Amano; S W Lee; A C Allison
Journal:  Mol Pharmacol       Date:  1993-02       Impact factor: 4.436

9.  Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes.

Authors:  J Bauer; T M Bauer; T Kalb; T Taga; G Lengyel; T Hirano; T Kishimoto; G Acs; L Mayer; W Gerok
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  3 in total

1.  Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis.

Authors:  Meng Wang; An-Dong Liu; Qian Niu; Xiao Feng; Yuan-Yi Zheng; Shuai-Jun Chen; Hui Xu; Qian Li; Guo-Qing Hou; Xiao-Yang Bi; Yu-Zhi Lu; Pei-Pei Cheng; Li-Mei Liang; Ye-Han Jiang; Li-Qin Zhao; Fei Liu; Lin-Jie Song; Li-Ling Zhou; Ling-Yan Xiao; Feng Chen; Shawn Shun-Cheng Li; Wan-Li Ma; Xuan Cao; Hong Ye
Journal:  Theranostics       Date:  2022-05-26       Impact factor: 11.600

2.  Effect of kramecyne on the inflammatory response in lipopolysaccharide-stimulated peritoneal macrophages.

Authors:  E Sánchez-Miranda; J Lemus-Bautista; S Pérez; J Pérez-Ramos
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-13       Impact factor: 2.629

3.  Inhibition of lipopolysaccharide-induced nitric oxide and prostaglandin E2 production by chloroform fraction of Cudrania tricuspidata in RAW 264.7 macrophages.

Authors:  Gabsik Yang; Kyungjin Lee; Mihwa Lee; Inhye Ham; Ho-Young Choi
Journal:  BMC Complement Altern Med       Date:  2012-12-10       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.